-
AbbVie Inc. (ABBV $225.64)
- $225.64 P/E (TTM): 170.24X Cap: $394.14B
- View ABBV Profile
- View Questions on ABBV
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Mondelez International Inc. (MDLZ $58.69)
- $58.69 P/E (TTM): 21.9X Cap: $75.44B
- View MDLZ Profile
- View Questions on MDLZ
-
AbbVie Inc. (ABBV $225.64)
- $225.64 P/E (TTM): 170.24X Cap: $394.14B
- View ABBV Profile
- View Questions on ABBV
-
Archer-Daniels-Midland Company (ADM $68.08)
- $68.08 P/E (TTM): 27.03X Cap: $32.34B
- View ADM Profile
- View Questions on ADM
-
Colgate-Palmolive Company (CL $91.89)
- $91.89 P/E (TTM): 25.36X Cap: $72.77B
- View CL Profile
- View Questions on CL
-
General Mills Inc. (GIS $45.62)
- $45.62 P/E (TTM): 8.74X Cap: $24.34B
- View GIS Profile
- View Questions on GIS
-
Johnson & Johnson (JNJ $230.75)
- $230.75 P/E (TTM): 21.94X Cap: $555.94B
- View JNJ Profile
- View Questions on JNJ
-
Coca-Cola Company (The) (KO $75.33)
- $75.33 P/E (TTM): 24.85X Cap: $321.80B
- View KO Profile
- View Questions on KO
-
Procter & Gamble Company (The) (PG $153.19)
- $153.19 P/E (TTM): 22.16X Cap: $352.71B
- View PG Profile
- View Questions on PG
-
Diageo plc (DEO $91.99)
- $91.99 P/E (TTM): 21.17X Cap: $51.06B
- View DEO Profile
- View Questions on DEO
-
Nestle SA ADR (NSRGY $97.24)
- $97.24 P/E (TTM): 1.39X Cap: $249.18B
- View NSRGY Profile
- View Questions on NSRGY
Q: Hi 5i, looking to upgrade my consumer goods stock buy selling Deo, gis and buying Nsrgy and mdlz. What do you think of this move and what would be a good entrance price. These companies are bigger and more diversified. Are there any other companies with a dividend worth looking at? Thank you for your service!
-
Intuitive Surgical Inc. (ISRG $496.73)
- $496.73 P/E (TTM): 66.61X Cap: $178.74B
- View ISRG Profile
- View Questions on ISRG
-
Vertex Pharmaceuticals Incorporated (VRTX $472.01)
- $472.01 P/E (TTM): 32.86X Cap: $119.75B
- View VRTX Profile
- View Questions on VRTX
-
AbbVie Inc. (ABBV $225.64)
- $225.64 P/E (TTM): 170.24X Cap: $394.14B
- View ABBV Profile
- View Questions on ABBV
-
Johnson & Johnson (JNJ $230.75)
- $230.75 P/E (TTM): 21.94X Cap: $555.94B
- View JNJ Profile
- View Questions on JNJ
-
Eli Lilly and Company (LLY $1,044.13)
- $1,044.13 P/E (TTM): 50.74X Cap: $987.10B
- View LLY Profile
- View Questions on LLY
-
Merck & Company Inc. (MRK $113.37)
- $113.37 P/E (TTM): 14.58X Cap: $281.38B
- View MRK Profile
- View Questions on MRK
-
iShares Biotechnology ETF (IBB $174.14)
- $174.14 P/E (TTM): 20.63X Cap: $8.51B
- View IBB Profile
- View Questions on IBB
-
IDEXX Laboratories Inc. (IDXX $639.60)
- $639.60 P/E (TTM): 53.17X Cap: $53.53B
- View IDXX Profile
- View Questions on IDXX
-
Halozyme Therapeutics Inc. (HALO $74.45)
- $74.45 P/E (TTM): 15.1X Cap: $8.43B
- View HALO Profile
- View Questions on HALO
-
Incyte Corporation (INCY $102.67)
- $102.67 P/E (TTM): 17.11X Cap: $19.64B
- View INCY Profile
- View Questions on INCY
-
Catalyst Pharmaceuticals Inc. (CPRX $25.00)
- $25.00 P/E (TTM): 14.13X Cap: $3.07B
- View CPRX Profile
- View Questions on CPRX
-
Gilead Sciences CDR (CAD Hedged) (GILD $29.18)
- $29.18 P/E (TTM): 373.55X Cap: $239.83B
- View GILD Profile
- View Questions on GILD
Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare
-
Alphabet Inc. (GOOG $344.90)
- $344.90 P/E (TTM): 33.42X Cap: $4.07T
- View GOOG Profile
- View Questions on GOOG
-
Intuitive Surgical Inc. (ISRG $496.73)
- $496.73 P/E (TTM): 66.61X Cap: $178.74B
- View ISRG Profile
- View Questions on ISRG
-
Booking Holdings Inc. (BKNG $5,122.25)
- $5,122.25 P/E (TTM): 32.58X Cap: $165.10B
- View BKNG Profile
- View Questions on BKNG
-
QUALCOMM Incorporated (QCOM $152.62)
- $152.62 P/E (TTM): 30.26X Cap: $163B
- View QCOM Profile
- View Questions on QCOM
-
AbbVie Inc. (ABBV $225.64)
- $225.64 P/E (TTM): 170.24X Cap: $394.14B
- View ABBV Profile
- View Questions on ABBV
-
McDonald's Corporation (MCD $318.53)
- $318.53 P/E (TTM): 26.88X Cap: $226.84B
- View MCD Profile
- View Questions on MCD
-
Altria Group Inc. (MO $62.23)
- $62.23 P/E (TTM): 11.83X Cap: $104.46B
- View MO Profile
- View Questions on MO
-
PepsiCo Inc. (PEP $155.20)
- $155.20 P/E (TTM): 29.21X Cap: $212.21B
- View PEP Profile
- View Questions on PEP
-
Procter & Gamble Company (The) (PG $153.19)
- $153.19 P/E (TTM): 22.16X Cap: $352.71B
- View PG Profile
- View Questions on PG
-
Prudential Financial Inc. (PRU $111.72)
- $111.72 P/E (TTM): 15.2X Cap: $43.53B
- View PRU Profile
- View Questions on PRU
-
United Rentals Inc. (URI $778.98)
- $778.98 P/E (TTM): 20.15X Cap: $49.07B
- View URI Profile
- View Questions on URI
-
Royal Bank of Canada (RY $230.51)
- $230.51 P/E (TTM): 15.72X Cap: $322.76B
- View RY Profile
- View Questions on RY
-
Constellation Software Inc. (CSU $2,454.25)
- $2,454.25 P/E (TTM): 57.48X Cap: $53.25B
- View CSU Profile
- View Questions on CSU
- View Reports on CSU
-
WSP Global Inc. (WSP $270.46)
- $270.46 P/E (TTM): 39.37X Cap: $34.37B
- View WSP Profile
- View Questions on WSP
- View Reports on WSP
-
Thomson Reuters Corporation (TRI $149.00)
- $149.00 P/E (TTM): 27.8X Cap: $66.92B
- View TRI Profile
- View Questions on TRI
-
Shopify Inc. Class A Subordinate Voting Shares (SHOP $180.62)
- $180.62 P/E (TTM): 95.83X Cap: $232.49B
- View SHOP Profile
- View Questions on SHOP
- View Reports on SHOP
-
Nutrien Ltd. (NTR $93.86)
- $93.86 P/E (TTM): 54.78X Cap: $45.31B
- View NTR Profile
- View Questions on NTR
-
Axon Enterprise Inc. (AXON $459.99)
- $459.99 P/E (TTM): 152.55X Cap: $38.38B
- View AXON Profile
- View Questions on AXON
-
EnerSys (ENS $186.26)
- $186.26 P/E (TTM): 21.07X Cap: $6.65B
- View ENS Profile
- View Questions on ENS
-
Berkshire Hathaway Inc. (BRK.B $487.29)
- $487.29 P/E (TTM): 15.37X Cap: $1.03T
- View BRK.B Profile
- View Questions on BRK.B
-
Trane Technologies plc (TT $425.09)
- $425.09 P/E (TTM): 32.38X Cap: $93.25B
- View TT Profile
- View Questions on TT
Q: I’m doing a fairly major portfolio clean-up and account optimization exercise.
Specifically, I’m removing dividend-oriented and income-generating stocks from my TFSA and RRSP that are better suited to a non-registered account, and reallocating TFSA/RRSP capital to assets that benefit most from tax sheltering.
At a broad level, I’d appreciate your perspective on:
• Which CAD and USD names are best suited to an RRSP (e.g., U.S. dividend payers, global compounders, cyclicals, etc.)
• Which CAD and USD names are best suited to a TFSA (long-term growth, compounding, low income leakage)
I’m less interested in yield optimization and more focused on long-term after-tax efficiency and proper account placement.
If helpful, feel free to answer at a category level (e.g., “U.S. dividend aristocrats,” “Canadian compounders,” etc.) or with specific examples you think are particularly well-suited.
Thanks — looking forward to your thoughts.
Specifically, I’m removing dividend-oriented and income-generating stocks from my TFSA and RRSP that are better suited to a non-registered account, and reallocating TFSA/RRSP capital to assets that benefit most from tax sheltering.
At a broad level, I’d appreciate your perspective on:
• Which CAD and USD names are best suited to an RRSP (e.g., U.S. dividend payers, global compounders, cyclicals, etc.)
• Which CAD and USD names are best suited to a TFSA (long-term growth, compounding, low income leakage)
I’m less interested in yield optimization and more focused on long-term after-tax efficiency and proper account placement.
If helpful, feel free to answer at a category level (e.g., “U.S. dividend aristocrats,” “Canadian compounders,” etc.) or with specific examples you think are particularly well-suited.
Thanks — looking forward to your thoughts.
Insiders
Share Information
SEC Filings
News and Media